Elkfork Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-4,752
Closed -$206K 1066
2019
Q2
$206K Buy
+4,752
New +$202K 0.01% 813
2018
Q4
Sell
-12,650
Closed -$565K 1058
2018
Q3
$565K Hold
12,650
0.01% 561
2018
Q2
$506K Hold
12,650
0.01% 527
2018
Q1
$507K Hold
12,650
0.01% 519
2017
Q4
$544K Hold
12,650
0.01% 515
2017
Q3
$630K Hold
12,650
0.02% 432
2017
Q2
$606K Hold
12,650
0.02% 444
2017
Q1
$572K Hold
12,650
0.02% 423
2016
Q4
$512K Buy
+12,650
New +$498K 0.02% 406

Other funds holding SNY

Elkfork Partners's SNY Position: Q3 2019 in Review

Elkfork Partners sold out of Sanofi (SNY) in Q3 2019, closing a stake of 4,752 shares — an estimated $206K sold.

Elkfork Partners first reported a position in SNY in Q4 2016 and held it in 9 quarters. The position peaked at $630K in Q3 2017. 485 funds tracked by Wall St. Rank hold SNY as of Q3 2019.

  • Elkfork Partners reported no remaining Sanofi position as of Q3 2019 after selling out during the quarter.
  • Elkfork Partners sold 4,752 Sanofi shares in Q3 2019, an estimated $206K.
  • Elkfork Partners first reported a position in Sanofi in Q4 2016 and held it in 9 quarters.
  • Elkfork Partners's Sanofi position peaked at $630K in Q3 2017.
  • 485 funds tracked by Wall St. Rank held Sanofi as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.